Showing results (1461-1470 of 1,498) with videos related to

Sort By:
Pageof 150
American Journal of Ophthalmology|June 26, 2018
Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International StudyNinel Z Gregori, Natalia F Callaway, Catherine Hoeppner, et al.
Journal of Crohn'S & Colitis|February 16, 2019
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab CohortN Plevris, C S Chuah, R M Allen, et al.
BMC Ophthalmology|May 8, 2016
Worldwide Argus II implantation: recommendations to optimize patient outcomesDevon H Ghodasra, Adrienne Chen, J Fernando Arevalo, et al.
Diabetes Care|May 12, 2017
Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes DatabaseAndrea O Y Luk, Eric M T Hui, Ming-Chuen Sin, et al.
JAMA Neurology|April 4, 2022
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseJohn J Chen, Saif Huda, Yael Hacohen, et al.
Oncogene|October 8, 2013
EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer riskI M Wilson, E A Vucic, K S S Enfield, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Form and function of actin impacts actin health and agingMaxim Averbukh, Hunter Nelson, Tiffany Wang, et al.
Journal of Medicinal Chemistry|May 14, 2014
Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutationsTed W Johnson, Paul F Richardson, Simon Bailey, et al.
European Urology|March 9, 2020
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic ReviewLisa Moris, Marcus G Cumberbatch, Thomas Van den Broeck, et al.
The Lancet. Oncology|December 13, 2021
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort studyMartin C Tammemägi, Mamta Ruparel, Alain Tremblay, et al.
Pageof 150